RACV launches new survey to address driving with chronic pain.
Many drivers can feel their muscles twinge after a long stint behind the wheel but for people with chronic pain, the challenge of driving for prolonged periods can impact their everyday lives. Experts say 14 per cent of Australians – 3.5 million people – suffer chronic pain, but many want to continue to drive.
The Therapeutic Goods Administration (TGA) announced on 15 December a final decision to down-schedule certain low dose cannabidiol (CBD) preparations from Schedule 4 (Prescription Medicine) to Schedule 3 (Pharmacist Only Medicine).
According to a statement released by the TGA this decision allows approved low-dose CBD-containing products (up to a maximum of 150mg/day) for use in adults, to be supplied OTC by a pharmacist, without prescription.
Painaustralia CEO speaks on tighter regulation of opioid use, #COVID19, and broader need for multidisciplinary pain management in Australia in the June 2020 issue of Retail Pharmacy. https://buff.ly/2U7DMPk
Researchers at the University of Sydney have used human stem cells to make pain-killing neurons that provide lasting relief in mice, without side effects, in a single treatment. Prof Paul Glare interviewed https://buff.ly/2U0Fwe9 ( also aired on Channel 10 News)